Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT04798469
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Hypogonadism, Male
- Opioid Use
- Pain
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Testosterone Undecanoate 250 MG/ML — DRUGIntramuscular administration at a dose of 750 mg at baseline, weeks 4, and week 14.
- Placebo — DRUGIntramuscular administration of placebo at baseline, weeks 4, and week 14.
Study Details
The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life when compared with placebo in men with chronic spinal pain treated with opioids who have opioid-induced hypogonadism (low testosterone).
Key Dates
- First listed
- Mar 15, 2021
- Start date
- Jan 10, 2022
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2027
- Completion
- Dec 30, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TestosteroneIntramuscular injections of testosterone undecanoate 750 mg.
- Placebo Comparator: PlaceboIntramuscular injections of placebo.
Primary Outcome Measure
Changes in scores in the Pain Interference Subscale of the Brief Pain Inventory (BPI) questionnaire [ Time Frame: Baseline, 3 months, and 6 months ]
Central Contacts
- Julia Crosby617-525-6726
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Shehzad Basaria, MD (PRINCIPAL_INVESTIGATOR) Robert R Edwards, PhD (PRINCIPAL_INVESTIGATOR) Vitaly Napadow, PhD (SUB_INVESTIGATOR) Thomas G Travison, PhD (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruiting · Boston Scientific Corporation · Greenwood Village, Colorado
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteronePHASE2 · Recruiting · Seattle Institute for Biomedical and Clinical Research · Boston, Massachusetts
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Little Rock, Arkansas
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts